Easy-to-understand Financial Insights
that build Wealth.

Biocon To Approve Q3 FY 2024-25 Financial Results In Board Meeting On January 30, Trading Window Closed From January 1

  • Biocon Limited has announced a Board meeting on January 30, 2025, to approve un-audited financial results for Q3 FY 2024-25.
  • The trading window for insiders will be closed from Januar…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

Learn More